181 related articles for article (PubMed ID: 7610054)
1. Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter.
Thompson JD; Ayers DF; Malmstrom TA; McKenzie TL; Ganousis L; Chowrira BM; Couture L; Stinchcomb DT
Nucleic Acids Res; 1995 Jun; 23(12):2259-68. PubMed ID: 7610054
[TBL] [Abstract][Full Text] [Related]
2. Retroviral vectors designed for targeted expression of RNA polymerase III-driven transcripts: a comparative study.
Ilves H; Barske C; Junker U; Böhnlein E; Veres G
Gene; 1996 Jun; 171(2):203-8. PubMed ID: 8666273
[TBL] [Abstract][Full Text] [Related]
3. The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization.
Bertrand E; Castanotto D; Zhou C; Carbonnelle C; Lee NS; Good P; Chatterjee S; Grange T; Pictet R; Kohn D; Engelke D; Rossi JJ
RNA; 1997 Jan; 3(1):75-88. PubMed ID: 8990401
[TBL] [Abstract][Full Text] [Related]
4. Use of a nonviral vector to express a chimeric tRNA-ribozyme against lymphocytic choriomeningitis virus: cytoplasmic accumulation of a catalytically competent transcript but minimal antiviral effect.
Gebhard JR; Perry CM; Mahadeviah S; Whitton JL
Antisense Nucleic Acid Drug Dev; 1997 Feb; 7(1):3-11. PubMed ID: 9055033
[TBL] [Abstract][Full Text] [Related]
5. Significantly higher activity of a cytoplasmic hammerhead ribozyme than a corresponding nuclear counterpart: engineered tRNAs with an extended 3' end can be exported efficiently and specifically to the cytoplasm in mammalian cells.
Kuwabara T; Warashina M; Koseki S; Sano M; Ohkawa J; Nakayama K; Taira K
Nucleic Acids Res; 2001 Jul; 29(13):2780-8. PubMed ID: 11433023
[TBL] [Abstract][Full Text] [Related]
6. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase.
Scherr M; Reed M; Huang CF; Riggs AD; Rossi JJ
Mol Ther; 2000 Jul; 2(1):26-38. PubMed ID: 10899825
[TBL] [Abstract][Full Text] [Related]
7. RNA-polymerase III-driven expression cassettes in human gene therapy.
Medina MF; Joshi S
Curr Opin Mol Ther; 1999 Oct; 1(5):580-94. PubMed ID: 11249665
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of the CCR5 beta-chemokine receptor and inhibition of HIV-1 infection by stable VA1-ribozyme chimeric transcripts.
Cagnon L; Rossi JJ
Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):251-61. PubMed ID: 10984119
[TBL] [Abstract][Full Text] [Related]
9. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: screening for effective target sites.
Kobayashi H; Takemura Y; Wang FS; Oka T; Ohnuma T
Int J Cancer; 1999 Jun; 81(6):944-50. PubMed ID: 10362143
[TBL] [Abstract][Full Text] [Related]
10. Expression of siRNA from a single transcript that includes multiple ribozymes in mammalian cells.
Kato Y; Taira K
Oligonucleotides; 2003; 13(5):335-43. PubMed ID: 15000824
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs.
Li MJ; Bauer G; Michienzi A; Yee JK; Lee NS; Kim J; Li S; Castanotto D; Zaia J; Rossi JJ
Mol Ther; 2003 Aug; 8(2):196-206. PubMed ID: 12907142
[TBL] [Abstract][Full Text] [Related]
12. Design, characterization and testing of tRNA3Lys-based hammerhead ribozymes.
Medina MF; Joshi S
Nucleic Acids Res; 1999 Apr; 27(7):1698-708. PubMed ID: 10076002
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA.
De Young MB; Kincade-Denker J; Boehm CA; Riek RP; Mamone JA; McSwiggen JA; Graham RM
Biochemistry; 1994 Oct; 33(40):12127-38. PubMed ID: 7918434
[TBL] [Abstract][Full Text] [Related]
14. Yeast expression vectors using RNA polymerase III promoters.
Good PD; Engelke DR
Gene; 1994 Dec; 151(1-2):209-14. PubMed ID: 7828876
[TBL] [Abstract][Full Text] [Related]
15. Transcripts containing a small anti-HIV hammerhead ribozyme that are active in the cell cytoplasm but inactive in vitro as free RNAs.
Domi A; Beaud G; Favre A
Biochimie; 1996; 78(7):654-62. PubMed ID: 8955908
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 in CEM cells by a potent TAR decoy.
Lee SW; Gallardo HF; Gaspar O; Smith C; Gilboa E
Gene Ther; 1995 Aug; 2(6):377-84. PubMed ID: 7584112
[TBL] [Abstract][Full Text] [Related]
17. Effective ribozyme delivery in plant cells.
Perriman R; Bruening G; Dennis ES; Peacock WJ
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6175-9. PubMed ID: 7597097
[TBL] [Abstract][Full Text] [Related]
18. Transport of intracellularly active ribozymes to the cytoplasm.
Miyagishi M; Kuwabara T; Taira K
Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S96-101. PubMed ID: 11587376
[TBL] [Abstract][Full Text] [Related]
19. Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein.
Wiechen K; Zimmer C; Dietel M
Cancer Gene Ther; 1998; 5(1):45-51. PubMed ID: 9476966
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression and HIV-1 inhibition of chimeric tRNA(Lys3)-ribozymes under dual U6 snRNA and tRNA promoters.
Chang Z; Westaway S; Li S; Zaia JA; Rossi JJ; Scherer LJ
Mol Ther; 2002 Oct; 6(4):481-9. PubMed ID: 12377189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
